ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ken Frazier to Chair Transcarent Board of Directors

Former Merck Chairman and CEO and One of TIME’s 100 Most Influential People Joins Board, Committed to Meaningful Change in the Healthcare Industry for Consumers and Employers

Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that industry leader Ken Frazier has been appointed to chair the company’s board of directors. This addition to the Board is a formative milestone for Transcarent. As one of the most influential Chief Executive Officers in healthcare, Frazier brings unmatched experience and business acumen to help shape Transcarent’s long-term growth strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230221005729/en/

Kenneth Frazier (Photo: Business Wire)

Kenneth Frazier (Photo: Business Wire)

Ken Frazier recently served as the Executive Chairman of the board of directors of Merck, where he was President and Chief Executive Officer for a decade, from 2011 to 2021. He is currently the chairman of General Catalyst’s Health Assurance Initiatives, focused on creating a more proactive, affordable, and equitable system of care.

“Ken’s experience in healthcare and business is unparalleled. He’s a seasoned executive and has been a member of some of the most prestigious industry boards including Merck and ExxonMobil,” said Glen Tullman, CEO of Transcarent. “Ken’s decision to join our Board further validates Transcarent’s mission to solve the industry’s most challenging issues, including making it easy for employees and their families to access high-quality, affordable health and care and ensuring the costs are manageable for employers who pay for care.”

Frazier is also a tireless advocate for social justice and economic inclusion. He co-founded and currently serves as co-chair of OneTen, a coalition of leading organizations committed to upskilling, hiring, and promoting one million Black Americans who lack four-year college degrees into family-sustaining jobs, of which Transcarent is a member. OneTen is committed to facilitating a meaningful, measurable, and lasting impact on our nation’s goal of equal opportunity.

“I’m not sure there is a problem more pressing than the accessibility and affordability of health and care to the average American worker,” said Ken Frazier. “Having run one of the largest companies in the country, I can tell you that the continued rapid escalation of healthcare costs will squeeze out other critical investments we need to make in this country, from infrastructure and innovation for businesses to education and national security for the U.S. government. I’m excited to join the Transcarent Board and to be part of an organization that is uniquely positioned to not only improve health and care delivery, but will do so in a way that makes it more equitable for the individual as well as their employer.”

About Transcarent

Transcarent is a health and care experience company that makes it easy for people to access high quality, affordable care. Through an integrated mobile or web platform, Members can access everyday care, for example, chat with a provider in less than 60 seconds, behavioral health, pharmacy care, care at home (or close to it), comprehensive surgical care, or receive additional care for complex care needs like cancer.

Transcarent takes accountability for results – offering at-risk pricing models and transparent impact reporting to align incentives towards measurably better experience, better health, and lower costs. For more Information, visit www.transcarent.com and follow on Twitter or LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.